ImageneBio Inc
48 hedge funds and large institutions have $168M invested in ImageneBio Inc in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 10 closing their positions.
0.01% less ownership
Funds ownership: 6.36% → 6.34% (-0.01%)
2% less funds holding
Funds holding: 49 → 48 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
51% less capital invested
Capital invested by funds: $343M → $168M (-$176M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$6.23M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.09M |
| 3 |
Barclays
London,
United Kingdom
|
+$1.82M |
| 4 |
BlackRock
New York
|
+$1.15M |
| 5 |
State Street
Boston,
Massachusetts
|
+$567K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.4M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.56M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$1.41M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$525K |
IMA Hedge Fund Activity: Q1 2022 in Review
48 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2022, worth a combined $168M — down 51% from $343M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of IMA and 9 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 13 added.
The largest buyer was BVF Inc, adding an estimated $6.23M. The largest seller was RA Capital Management, exiting entirely with an estimated $9.4M sold.
- 48 institutional investors held ImageneBio Inc (IMA) as of Q1 2022, down from 49 in Q4 2021.
- Funds reported $168M of ImageneBio Inc stock for Q1 2022, down 51% quarter-over-quarter.
- 9 funds opened new ImageneBio Inc positions in Q1 2022 and 10 closed out, a net change of -1 holder.
- The largest ImageneBio Inc buyer in Q1 2022 was BVF Inc, an estimated $6.23M added.
- The largest ImageneBio Inc seller in Q1 2022 was RA Capital Management, an estimated $9.4M sold.
Based on aggregated 13F filings for Q1 2022.